Short Interest in Cutera, Inc. (NASDAQ:CUTR) Increases By 8.9%

Cutera, Inc. (NASDAQ:CUTR) was the recipient of a significant increase in short interest in November. As of November 30th, there was short interest totalling 4,400,000 shares, an increase of 8.9% from the November 15th total of 4,040,000 shares. Based on an average daily volume of 290,700 shares, the days-to-cover ratio is currently 15.1 days.

Analyst Ratings Changes

Separately, StockNews.com initiated coverage on shares of Cutera in a research note on Thursday, December 12th. They set a “sell” rating on the stock.

Cutera Price Performance

Shares of CUTR opened at $0.35 on Tuesday. The business’s 50 day simple moving average is $0.51 and its 200-day simple moving average is $0.96. Cutera has a 1 year low of $0.28 and a 1 year high of $4.97. The stock has a market capitalization of $7.15 million, a price-to-earnings ratio of -0.05 and a beta of 1.26.

Institutional Trading of Cutera

A number of large investors have recently made changes to their positions in CUTR. Ground Swell Capital LLC bought a new stake in shares of Cutera in the 2nd quarter valued at about $37,000. Bank of Montreal Can lifted its holdings in shares of Cutera by 14.2% during the 2nd quarter. Bank of Montreal Can now owns 282,704 shares of the medical device company’s stock valued at $455,000 after purchasing an additional 35,248 shares during the last quarter. Finally, Squarepoint Ops LLC boosted its position in Cutera by 164.5% in the 2nd quarter. Squarepoint Ops LLC now owns 113,964 shares of the medical device company’s stock worth $172,000 after purchasing an additional 70,870 shares in the last quarter. 90.70% of the stock is owned by hedge funds and other institutional investors.

About Cutera

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.